| CXSL2100081 | IBI321 | IBI-321 | Injection | Biological Products(1) | New Drug Application | 2021-03-04 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-03-03 | view |
| CYSB2100055 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2021-02-06 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2022-01-27 | view |
| CXHL2100072 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
| CXHL2100071 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
| CXHL2100073 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
| CXSL2100029 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2021-01-23 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-22 | view |
| CXSS2100008 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-12 | view |
| CXSS2100007 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2021-11-05 | view |
| CXSS2100009 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-12 | view |
| CXSB2100002 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2021-01-06 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2021-09-02 | view |
| CYSB2100001 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-01-06 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2022-01-27 | view |
| JXHL2000323 | Parsaclisib片 | parsaclisib | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-12-14 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-12-10 | view |
| JXHL2000322 | Parsaclisib片 | parsaclisib | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-12-14 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-12-10 | view |
| CXSL2000304 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2020-10-28 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-10-27 | view |
| CYSB2000230 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2020-10-20 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-12-28 | view |
| CYSB2000225 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2020-10-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-12-28 | view |
| CYSB2000220 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2020-09-30 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-11-26 | view |
| CYSB2000219 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2020-09-30 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-12-28 | view |
| CXSL2000274 | IBI318 | IBI318 | Injection | Biological Products(1) | New Drug Application | 2020-09-28 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-28 | view |
| CXSL2000263 | IBI188 | letaplimab | Injection | Biological Products(1) | New Drug Application | 2020-09-12 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-09-11 | view |
